Xiaobo Wan
万小波
Xiaobo Wan is a biotech entrepreneur and the co-founder and CEO of CompMedChem (康迈迪森), an AI-driven drug discovery company launched in 2020 with backing from FreeS Fund (峰瑞资本), as per multiple FreeS Fund pieces from 2020–2021 . He holds a PhD and was featured as a representative "returnee entrepreneur" in FreeS Fund's 2021 China-US VC forums, where he discussed the challenges and advantages of building a biotech startup in China after returning from abroad . At the time, CompMedChem was actively hiring computational chemists, AI algorithm engineers, and protein prediction researchers in Beijing .
elsewhere's corpus does not cover this subject beyond 2021.
AI-generated — may contain errors, please verify.
Coverage
Biotech Firms Raise Nearly 4 Billion Yuan, Consumer Companies Land Over 1.4 Billion | FreeS Family Funding Roundup · August
We've also released three short videos this week — follow us to check them out.
峰瑞资本·Are Returnee Entrepreneurs Losing Their Edge? | 2021 FreeS Fund China-US Venture Forum Transcript
Launch a Startup or Take the "Soft Landing" Through Employment?
峰瑞资本·What's It Like Doing Venture Capital in China? | 2021 FreeS Fund China-US VC Forum Transcript
How do you know if you're cut out for investing? What challenges will you face along the way?
峰瑞资本·FreeS Report 21: In Search of China's Classics and Fashion — A Study on Guochao Consumption | FreeS Research Institute
Every category will see the rise of influential guochao brands.
峰瑞资本·FreeS Fund China-US Venture Capital Forum Registration Now Open | Seizing New Opportunities in China's Era
Whether you're looking for a job or starting a company, feel free to come chat with us at FreeS Fund.
峰瑞资本·Why Is AI Drug Discovery So Hot, and Why Now? | FreeS Fund Biomedical VC Summit Transcript
Why We're Bullish on AI Drug Discovery
峰瑞资本·Why Is AI Drug Discovery So Hot? And How Long Will It Stay Hot? | FreeS Fund Events & Research Recs
Three Slightly Brain-Burning Little Gifts
峰瑞资本·
